Cargando…

Commentary on “Seasonal Variation of Drug Prescription Rate for Overactive Bladder in Men Based on National Health Insurance Claims Data, 2012–2016”

Detalles Bibliográficos
Autores principales:	Tae, Bum Sik, Bae, Jae Hyun, Choi, Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Continence Society 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022164/ https://www.ncbi.nlm.nih.gov/pubmed/33819962 http://dx.doi.org/10.5213/inj.2142014.007

Ejemplares similares

Reply to the Commentary on “Seasonal Variation of Drug Prescription Rate for Overactive Bladder in Men Based on National Health Insurance Claims Data, 2012–2016”
por: Kim, Jong Won, et al.
Publicado: (2021)

Seasonal Variation of Drug Prescription Rate for Overactive Bladder in Men Based on National Health Insurance Claims Data, 2012–2016
por: Kim, Jong Won, et al.
Publicado: (2020)

Seasonal Variation of Overactive Bladder Symptoms in Female Patients
por: Tae, Bum Sik, et al.
Publicado: (2019)

Inequities in Filled Overactive Bladder Medication Prescriptions in the US
por: Luchristt, Douglas, et al.
Publicado: (2023)

A Comparison of the Anesthetic Methods for Recurrence Rates of Bladder Cancer after Transurethral Resection of Bladder Tumors Using National Health Insurance Claims Data of South Korea
por: Lee, Sang Won, et al.
Publicado: (2022)

K-means clustering of outpatient prescription claims for health insureds in Iran
por: Momahhed, Shekoofeh Sadat, et al.
Publicado: (2023)

Here Is the Case for the Urge in Administrative Claims Database Research About Overactive Bladder Therapies
por: Szeinbach, Sheryl L., et al.
Publicado: (2008)

Impact of a direct-to-consumer information campaign on prescription patterns for overactive bladder
por: Zaitsu, Masayoshi, et al.
Publicado: (2018)

The Urobiome and Its Role in Overactive Bladder
por: Bae, Sangrak, et al.
Publicado: (2022)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Diagnostic Tool for Assessing Overactive Bladder Symptoms: Could the International Prostate Symptom Storage Subscore Replace the Overactive Bladder Symptom Score?
por: Shim, Ji Sung, et al.
Publicado: (2016)

Analysis of the prevalence and associated factors of overactive bladder in adult Korean men
por: Kim, So Young, et al.
Publicado: (2017)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Frequency and Cost of Claims by Injury Type From the Korea Workers’ Compensation Insurance Between 2016 and 2019
por: Bae, Suk Won, et al.
Publicado: (2023)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

The role of prescription drugs in female overactive bladder syndrome—A population‐wide cohort study
por: Umek, Wolfgang, et al.
Publicado: (2019)

Opioid Prescription Claims Among Women of Reproductive Age — United States, 2008–2012
por: Ailes, Elizabeth C., et al.
Publicado: (2015)

Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis
por: Sussman, D., et al.
Publicado: (2017)

Treatment Patterns for Patients on Overactive Bladder Therapy: A Retrospective Statistical Analysis Using Canadian Claims Data
por: Wagg, Adrian, et al.
Publicado: (2016)

Prevalence of Analgesic Prescriptions among Patients with Cancer in Japan: An Analysis of Health Insurance Claims Data
por: Higashi, Takahiro, et al.
Publicado: (2012)

Determinants of Growth in Prescription Drug Spending Using 2010–2019 Health Insurance Claims Data
por: Lee, HyeYeong, et al.
Publicado: (2021)

Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database
por: Hu, Eric, et al.
Publicado: (2023)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Medical management of overactive bladder
por: Ubee, Sarvpreet S., et al.
Publicado: (2010)

Overactive bladder in the vulnerable elderly
por: Wolff, Gillian F, et al.
Publicado: (2014)

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Review of the epidemiology of overactive bladder
por: Eapen, Renu S, et al.
Publicado: (2016)

Impact of depression on overactive bladder
por: Kawahara, Takashi, et al.
Publicado: (2020)

Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021)

Update on the management of overactive bladder
por: Fontaine, Christina, et al.
Publicado: (2021)

Mediterranean Diet and Overactive Bladder
por: Bozkurt, Yunus Erol, et al.
Publicado: (2022)

Telemedicine in Overactive Bladder Syndrome
por: Jericevic, Dora, et al.
Publicado: (2023)

Updates of Overactive Bladder in Pediatrics
por: Shim, Jisung, et al.
Publicado: (2023)

Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison With Overactive Bladder-dry
por: Hsiao, Sheng-Mou, et al.
Publicado: (2019)

Persistence and compliance with medication management in the treatment of overactive bladder
por: Kim, Tae Heon, et al.
Publicado: (2016)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
por: Tannenbaum, Stacey, et al.
Publicado: (2020)

Current role of treatment in men with lower urinary tract symptoms combined with overactive bladder
por: Lee, Seung Hwan, et al.
Publicado: (2014)

Health Insurance Claim Review Using Information Technologies
por: Park, Young-Taek, et al.
Publicado: (2012)

Hospital Claims and the Insurance Surplus
Publicado: (1921)

Association of Urinary Urgency and Delay Time of Micturition in Women With Overactive Bladder
por: Park, Kyung Kgi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8k025a5ft487j992a54ego4s2m